Monte Rosa Therapeutics, Inc. Common Stock vs. Twist Bioscience Corporation Common Stock
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
$12.13 -3.73%
VS TWSTTwist Bioscience Corporation Common Stock
$166.99 +7.35%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 4 of 5 compared factors.
Size & Scale
| GLUE | TWST | |
|---|---|---|
| Market Cap | $1.03 billion | $11.07 billion |
| Revenue (TTM) | — | $431.80 million |
| Net Income (TTM) | $-161,090,000 | $-136,717,000 |
TWST leads on 2 of 2 size & scale factors.
Valuation
| GLUE | TWST | |
|---|---|---|
| Price / Book | 2.12 | 24.84 |
| Price / Sales | — | 25.64 |
GLUE leads on 1 of 1 valuation factors.
Profitability
| GLUE | TWST | |
|---|---|---|
| Net Margin | — | -31.66% |
| Return on Equity | -33.06% | -30.67% |
TWST leads on 1 of 1 profitability factors.
Risk & Sentiment
| GLUE | TWST | |
|---|---|---|
| Short Interest | 0.86% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: GLUE overview, GLUE financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.